Clinical trials of new drugs for Alzheimer disease: a 2020–2023 update

Alzheimer's disease (AD) is the leading cause of dementia, presenting a significant unmet medical need worldwide. The pathogenesis of AD involves various pathophysiological events, including the accumulation of amyloid and tau, neuro-inflammation, and neuronal injury. Clinical trials focusing o...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Li-Kai, Kuan, Yi-Chun, Lin, Ho-Wei, Hu, Chaur-Jong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10544555/
https://www.ncbi.nlm.nih.gov/pubmed/37784171
http://dx.doi.org/10.1186/s12929-023-00976-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10544555/
https://www.ncbi.nlm.nih.gov/pubmed/37784171
http://dx.doi.org/10.1186/s12929-023-00976-6

Ejemplares similares